Sunday, December 21, 2025 | 07:56 AM ISTहिंदी में पढें
Glenmark Q2
Glenmark Pharma shines as September quarter marks rebound in earnings
Analysts are upgrading their ratings as they expect sales momentum in the US and domestic markets to improve
 "Glenmark Pharma shines as September quarter marks rebound in earnings")
Updated On : 18 Nov 2019 | 10:27 PM IST
Glenmark Q2 net down 4.23% at Rs 214 crore
The overall performance was driven by our India, Europe and API business: Glenmark Pharmaceuticals
 "Glenmark Q2 net down 4.23% at Rs 214 crore")
Updated On : 02 Nov 2017 | 8:26 PM IST
